Press/Media
- 21 results
Search results
-
More Progress for Bladder-Sparing Strategies in Muscle-Invasive Cancer
02/19/25
1 item of Media coverage
Press/Media
-
New Data on Advances in Bladder-Preserving Treatment Presented by Fox Chase Cancer Center Researchers
02/14/25
1 item of Media coverage
Press/Media
-
Targeted Combination Shows Promise in Metastatic Kidney Cancer
11/13/24
1 item of Media coverage
Press/Media
-
-
Fox Chase Cancer Center and Temple Health Present Research at the 2024 American Society of Clinical Oncology Annual Meeting
Dotan, E., Ghatalia, P., Edelman, M. & Bauman, J.
05/31/24 → 06/1/24
2 items of Media coverage
Press/Media
-
New Fox Chase Study Finds Immunotherapy Effective for Both Black and White Patients With Metastatic Renal Cell Carcinoma
01/26/24
1 item of Media coverage
Press/Media
-
No Boost in Outcomes for Clear Cell RCC With Higher Belzutifan Dose
11/13/23
1 item of Media coverage
Press/Media
-
Findings support 120 mg daily as preferred belzutifan dose for advanced clear cell RCC
11/11/23
1 item of Media coverage
Press/Media
-
New Bladder Cancer Findings Reported from Fox Chase Cancer Center (Neoadjuvant Chemotherapy With Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin In Patients With Muscle-invasive Bladder Cancer: a Retrospective Age-stratified ...)
Plimack, E. R., Ghatalia, P., Zibelman, M. R. & Geynisman, D.
09/18/23
1 item of Media coverage
Press/Media
-
New Study Findings from Fox Chase Cancer Center Illuminate Research in Carcinomas (Role of perioperative immunotherapy in localized renal cell carcinoma)
08/11/23
1 item of Media coverage
Press/Media
-
U.S. Clinical Trial: Fox Chase Cancer Center Listed a New Clinical Trial to Study Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
06/28/23
1 item of Media coverage
Press/Media
-
Temple University Health System Researcher Provides New Data on Bladder Cancer (Survival outcomes in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy stratified by number of cycles)
Plimack, E. R., Ghatalia, P., Zibelman, M. R. & Geynisman, D.
06/16/23
1 item of Media coverage
Press/Media
-
Fox Chase Cancer Center and Temple Health Present Research at the 2023 ASCO Annual Meeting
Vijayvergia, N., Borghaei, H., Khanal, R., Plimack, E. R., Reese, J. B., Ghatalia, P., Bleicher, R., Bauman, J., Bauerle Bass, S., Hall, M. J., Zibelman, M. R., Geynisman, D., Wei, S. & Williams, A. D.
06/2/23
1 item of Media coverage
Press/Media
-
Fox Chase Cancer Center Researcher Adds New Study Findings to Research in Bladder Cancer [A phase II trial of risk-enabled therapy after initiating neoadjuvant chemotherapy for bladder cancer (RETAIN)]
Plimack, E. R., Kutikov, A., Hallman, M. A., Uzzo, R. G., Ghatalia, P., Viterbo, R., Abbosh, P., Zibelman, M. R. & Geynisman, D.
04/3/23
1 item of Media coverage
Press/Media
-
Fox Chase Cancer Center: Two Fox Chase Researchers Receive Grants to Pursue Innovative Kidney Cancer Research
11/15/22
1 item of Media coverage
Press/Media
-
Around Town
Ghatalia, P., Patel, S. A., Reddy, S. S., Farma, J. M., Tagai, E. K. & Williams, A. D.
11/15/22
1 item of Media coverage
Press/Media
-
Fox Chase Receives NIH Grant to Develop Urine Test for Bladder Cancer Remaining After Treatment
06/2/21
1 item of Media coverage
Press/Media
-
Six Fox Chase Cancer Center Doctors Named ‘Top Physicians Under 40’ in Pennsylvania
04/19/21
1 item of Media coverage
Press/Media
-
Temple University Health System: Six Fox Chase Cancer Center Doctors Named 'Top Physicians Under 40' in Pennsylvania
Manley, C. J., Ghatalia, P. & Greco, S. H.
04/19/21
1 item of Media coverage
Press/Media
-
Liquid biopsies helpful in prostate cancer, but most not ready for routine use
01/29/21
1 item of Media coverage
Press/Media